MVision AI

Radiotherapy is involved in the treatment of roughly half of all cancer patients worldwide. Yet the specialists needed to deliver it are in short supply across much of the globe.

In Africa, more than 20 countries have no radiotherapy services at all. In the UK, the NHS currently has a 15% shortfall of clinical oncologists, with that figure projected to rise. A recent global analysis estimated that around 84,600 radiation oncologists will be needed worldwide by 2050, compared to an estimated 51,000 in 2022.

Our latest article explores where radiation oncologist shortages are most severe, what is driving them, and what can be done to address the problem.

Read the full article here: https://bit.ly/3Q6oj2A

On July 14, MVision AI and Xiel are bringing users together in Birmingham for a day focused on how MVision is being used in practice.

The agenda covers auto-contouring, synthetic imaging, dose prediction, and more — with presentations and Q&A led by clinical users working with our AI-powered platform in their department

If you are working with MVision or want to understand how others are getting the most from it, this is a good room to be in. The event will also be streamed live for those who cannot make it to Birmingham in person.

Contact [email protected] to secure your place.

Lyon in June is a good place to talk medical physics. MVision AI will be at the 64th SFPM Scientific Days, June 17–19 at the Cité Internationale.

Our Chief Scientific Officer Gregory Bolard will be there together with our partner Meditest at booth 19. Stop by to discuss how MVision Workspace+® supports radiotherapy preparation workflows -- from AI-assisted contouring to synthetic imaging, dose prediction, and contour propagation.

If you are attending, we would be glad to connect.



CE-marked (CE 2797) medical device under EU MDR 2017/745; Workspace+ is not available in all markets.

MVision Contour+® now supports over 300 structures for CT and MR, covering the entire body. Each structure sits within a pre-defined model, built on peer-reviewed contouring guidelines including ESTRO, RTOG, EPTN, GHG, and CORSAIR.

Now you can search the full library directly on our website. Filter by CT or MR, browse by anatomical site, and pull up details on anatomy, model availability, and guideline compliance for any structure.

See what Contour+ supports: https://bit.ly/4uncDpU

MVision AI will attend the 2026 AAMD Annual Meeting, taking place June 7–10 in Orlando, Florida.

The meeting brings together medical dosimetrists and radiation oncology professionals for educational sessions, workshops, and discussions focused on current developments in treatment planning and clinical practice.

Martin Clay, VP of Sales US, will be at Booth #102 during the exhibition.

Stop by to say hello and learn more about our AI-powered solutions for radiotherapy planning preparation.

As radiotherapy departments face growing patient volumes and increasing pressure on clinical resources, many teams are exploring where AI can make a meaningful difference.

In this edition of 'Expert Perspectives: AI in Radiotherapy', Christoph Dumke, Dr. med., from Vivantes Berlin-Spandau shares his perspective on how AI-supported contouring is already helping improve workflow efficiency, reduce variability, and support more standardised treatment preparation.

He also reflects on the future of AI-driven planning and personalised radiotherapy workflows.

Read the full interview: https://bit.ly/4flO2yc

Imaging has always been at the core of radiotherapy. What is evolving is the role it plays in planning, adaptation, and daily decision-making.

Synthetic CT is becoming an important component of these evolving workflows. It supports MR-only planning by removing the need for CT simulation, enables reliable dose calculation from CBCT for adaptive workflows, and helps address the dosimetric impact of contrast when enhanced scans are clinically necessary.

These capabilities are increasingly relevant as departments look to maintain precision while managing growing clinical complexity.

Our latest article explores the clinical evidence behind synthetic CT across MR-only, adaptive, and contrast-enhanced workflows, and what these developments mean for patient care.

You can read the full article here: https://bit.ly/3PNPONV

Every 9 seconds, someone in the EU is diagnosed with cancer.

During the European Week Against Cancer, we recognize the importance of prevention, research, early detection, and equal access to care for patients across Europe.

At MVision AI, we believe technology can help healthcare teams work more efficiently and consistently in radiotherapy planning. Our AI-powered solutions are designed to reduce repetitive manual work and support clinicians in delivering high-quality care with confidence.

We’re proud to contribute to a future where innovation helps improve cancer care pathways for both clinicians and patients.

Day 3 at , and the conversations keep flowing. We're excited about all the buzz around MVision Workspace® and Image+.

It’s been great welcoming visitors to Booth C14:31, sharing ideas, and demonstrating what we’ve been working on.

Thank you to everyone who has stopped by so far.

If you haven’t had the chance yet, come visit us or schedule a demo here:
https://bit.ly/43e8SIk



*CE-marked (CE 2797) medical device under EU MDR 2017/745; Workspace+ not available in all markets.